Glucotrack, Inc. current report, 30 July 2019

Business Context and Reporting Period

This Form 8-K was filed by Integrity Applications, Inc. (not Glucotrack, Inc.) on August 5, 2019, reporting events occurring on July 30, 2019. The company is incorporated in Delaware and maintains its principal executive offices in Ashdod, Israel. The filing addresses corporate governance changes rather than financial performance.

Key Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current report regarding personnel changes and does not contain financial statements or operational metrics.

Material Changes

The material change reported is the appointment of Shimon Rapps as a Director of the Company, effective July 30, 2019. No financial or operational changes were disclosed in this document.

Guidance, Outlook, and Risks

The filing contains no guidance, outlook, management commentary on future performance, or discussion of risks and contingencies. The document focuses solely on the background and qualifications of the newly appointed director.

Important Facts for Investors to Verify

  • Confirm the correct registrant name is Integrity Applications, Inc., as the input metadata referenced Glucotrack, Inc.
  • Verify the qualifications of Shimon Rapps, who brings experience in investment banking, M&A, and corporate governance from Andrew Garrett, Inc.
  • Note that the company has no securities registered under Section 12(b) of the Exchange Act.
  • Check subsequent filings for financial data, as this 8-K contains no financial metrics.